BioSpace News Archive

Cortexyme to Present at Canaccord Genuity’ s 41 st Annual Growth Conference on August 11 th

Better Therapeutics, Inc. to Present at the Canaccord Genuity’s 41 st Annual Growth Conference

Strand Therapeutics today announced that the company was awarded two Phase I Small Business Innovation Research (SBIR) grants from the National Cancer Institute (NCI) of the National Institutes of Health (NIH) to develop mRNA-based therapeutics for melanoma and triple negative breast cancer (TNBC).

VolitionRx Limited (NYSE AMERICAN: VNRX) (“Volition”) today announced it will host a conference call on Thursday, August 12 , at 8:00 a.m. Eastern time to discuss its financial and operating results for the second quarter of 2021, in addition to providing a business update.

UroGen Pharma Reports Second Quarter 2021 Financial Results and Recent Corporate Developments

Aditxt, Inc. today announced its Psoriasis clinical program will now be slated for 2022 instead of December 2021 as previously announced.

Agrawal will oversee and expand collaborations with BioPharma organizations to support and accelerate the development of innovative cancer treatments

Daxor Corporation(NYSE MKT: DXR), the global leader in blood volume measurement technology, today announces new data published in the journal Critical Care showing Daxor’s unique BVA-100 diagnostic blood test provides insights into the pathophysiology of volume derangements and capillary distress in critically ill COVID-19 patients enabling improved care.

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that upon completion of a number of preclinical and safety studies, it had executed an exclusive license agreement for an investigational gene therapy candidate, calpain 3 (CAPN-3), to treat Limb-girdle muscular dystrophy type 2A (LGMD2A), developed by the Abigail Wexner Research Institute at Nationwide Children’s Hospital (Nationwide Children’s).

Artelo Biosciences, Inc. today announced the publication of study results in Medical Cannabis and Cannabinoids, a peer-reviewed journal.